BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2001
View Archived Issues
Thiazolinediones may provide therapeutic benefits in demyelinating diseases
Read More
Research grant awarded for isolating potential anticancer agents from mushrooms
Read More
Atugen enters evaluation agreement with Byk Gulden
Read More
Paradigm and StemCo collaborate on biochemical profiling of adult human stem cells
Read More
Bayer enters postgenomics collaboration
Read More
AERx iDMS at least as effective as subcutaneous insulin in type 2 diabetics
Read More
Antitumor effects of COX-2-specific inhibitor JTE-522 described at Japanese meeting
Read More
Exelixis to acquire Genomica
Read More
Phase II study initiated for ISIS-104838 in rheumatoid arthritis
Read More
Virulizin enters phase III for treatment of pancreatic cancer
Read More
Shire acquires license to compound for Parkinson's disease
Read More
Oxford GlycoSciences and Teva sign agreement for Vevesca in Israel
Read More
Various presentations at Oxygen Society meeting highlight broad-spectrum potential of SOD mimetics
Read More
Antisense inhibitor of HCV yields encouraging preliminary results in chronically infected patients
Read More
Pharmacokinetic and safety analyses of phase I Heptazyme trial in HCV presented at AASLD
Read More
Breakthrough treatment for severe sepsis approved for the first time
Read More
Inhibition of IL-6 binding produces clinical improvement in RA
Read More
Investigational anti-TNF antibody improves clinical measures of RA and joint destruction
Read More
Regeneron proceeds to phase II trials with IL-1 Trap following promising phase I findings
Read More
HIV protease inhibitors claimed in recent patent by Pharmacor team
Read More
Merck reports new MC4 receptor agonists and potential uses for these compounds
Read More
Two Pharmacia patents cover novel antiviral agents particularly useful against herpesviruses
Read More
Alcon identifies several related series of antiglaucoma agents
Read More